Primary |
Diabetes Mellitus |
54.5% |
Gestational Diabetes |
18.2% |
Product Used For Unknown Indication |
9.1% |
Type 2 Diabetes Mellitus |
9.1% |
Hyperglycaemia |
4.5% |
Type 1 Diabetes Mellitus |
4.5% |
|
Maternal Exposure During Pregnancy |
20.0% |
Weight Increased |
20.0% |
Ketosis |
15.0% |
Blood Glucose Increased |
10.0% |
Foetal Exposure During Pregnancy |
10.0% |
Hyperglycaemia |
5.0% |
Hyperhidrosis |
5.0% |
Malaise |
5.0% |
Skin Exfoliation |
5.0% |
Suicide Attempt |
5.0% |
|
Secondary |
Type 1 Diabetes Mellitus |
25.5% |
Type 2 Diabetes Mellitus |
23.3% |
Diabetic Ketoacidosis |
15.0% |
Diabetes Mellitus |
10.6% |
Drug Use For Unknown Indication |
7.5% |
Suicide Attempt |
4.1% |
Depression |
2.2% |
Acute Coronary Syndrome |
1.8% |
Cardiac Failure Congestive |
1.3% |
Angina Pectoris |
1.2% |
Hypertension |
1.2% |
Essential Hypertension |
0.9% |
Sleep Disorder |
0.9% |
Thrombosis Prophylaxis |
0.9% |
Hypothyroidism |
0.7% |
Product Used For Unknown Indication |
0.7% |
Blood Cholesterol Increased |
0.6% |
Fluid Replacement |
0.6% |
Gestational Diabetes |
0.6% |
Hyperthyroidism |
0.6% |
|
Weight Increased |
13.4% |
Suicide Attempt |
11.0% |
Death |
7.3% |
Wrong Drug Administered |
7.3% |
Drug Ineffective |
6.1% |
Memory Impairment |
6.1% |
Pregnancy |
6.1% |
Small For Dates Baby |
6.1% |
Road Traffic Accident |
4.9% |
Diabetic Complication |
3.7% |
Hypoglycaemic Coma |
3.7% |
Renal Failure Acute |
3.7% |
Vaginal Haemorrhage |
3.7% |
Abdominal Pain |
2.4% |
Asthma |
2.4% |
Atrial Fibrillation |
2.4% |
Blindness |
2.4% |
Blood Glucose Increased |
2.4% |
Cardiac Disorder |
2.4% |
Cerebral Haemorrhage |
2.4% |
|
Concomitant |
Product Used For Unknown Indication |
28.9% |
Drug Use For Unknown Indication |
23.6% |
Diabetes Mellitus |
9.1% |
Hypertension |
7.2% |
Type 2 Diabetes Mellitus |
4.4% |
Rheumatoid Arthritis |
3.6% |
Prophylaxis |
3.2% |
Pain |
2.4% |
Graft Versus Host Disease |
2.1% |
Type 1 Diabetes Mellitus |
2.1% |
Hiv Infection |
1.6% |
Insomnia |
1.6% |
Atrial Fibrillation |
1.6% |
Prophylaxis Against Renal Transplant Rejection |
1.6% |
Nausea |
1.4% |
Breast Cancer |
1.2% |
Depression |
1.1% |
Neoplasm Malignant |
1.1% |
Premedication |
1.1% |
Asthma |
1.1% |
|
Vomiting |
12.4% |
Renal Failure Acute |
8.3% |
Weight Increased |
7.3% |
Pruritus |
6.2% |
Rhabdomyolysis |
6.2% |
Hypoglycaemia |
5.2% |
Nausea |
5.2% |
Respiratory Failure |
5.2% |
Peripheral Vascular Disorder |
4.7% |
Hyperglycaemia |
4.1% |
Neutropenia |
4.1% |
Injection Site Pain |
3.6% |
Somnolence |
3.6% |
Staphylococcal Infection |
3.6% |
Staphylococcal Sepsis |
3.6% |
Tremor |
3.6% |
Urinary Tract Infection |
3.6% |
Blood Glucose Increased |
3.1% |
Graft Versus Host Disease |
3.1% |
Myalgia |
3.1% |
|
Interacting |
Type 2 Diabetes Mellitus |
69.2% |
Blood Cholesterol Increased |
15.4% |
Gastric Disorder |
7.7% |
Thyroid Disorder |
7.7% |
|
Gastric Disorder |
50.0% |
Skin Ulcer |
50.0% |
|